✦ LIBER ✦

Predictors of outcome following myeloablative allo-SCT for therapy-related myelodysplastic syndrome and AML

✍ Scribed by Nevill, T J; Hogge, D E; Toze, C L; Nantel, S H; Power, M M; Abou Mourad, Y R; Song, K W; Lavoie, J C; Forrest, D L; Barnett, M J

Book ID: 109840377
Publisher: Nature Publishing Group
Year: 2008
Tongue: English
Weight: 156 KB
Volume: 42
Category: Article
ISSN: 0007-1188
DOI: 10.1038/bmt.2008.226

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum ferritin and disease status at tra

Serum ferritin and disease status at transplantation predict the outcome of allo-SCT in patients with AML or myelodysplastic syndrome

✍ Tachibana, T; Takasaki, H; Tanaka, M; Maruta, A; Hyo, R; Ishigatsubo, Y; Kanamor 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 148 KB

IPSS Poor-Risk Karyotype as a Predictor

IPSS Poor-Risk Karyotype as a Predictor of Outcome for Patients with Myelodysplastic Syndrome following Myeloablative Stem Cell Transplantation

✍ Thomas J. Nevill; John D. Shepherd; Heather J. Sutherland; Yasser R. Abou Mourad 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 297 KB

CD34+ lineage specific donor cell chimer

CD34+ lineage specific donor cell chimerism for the diagnosis and treatment of impending relapse of AML or myelodysplastic syndrome after allo-SCT

✍ Rosenow, F; Berkemeier, A; Krug, U; Müller-Tidow, C; Gerss, J; Silling, G; Groth 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 360 KB

Prediction of therapy-related acute myel

Prediction of therapy-related acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS) after autologous bone marrow transplant (ABMT) for lymphoma

✍ Legare, Robert D.; Gribben, John G.; Maragh, Marlon; Hermanowski-Vosatka, Anne; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB 👁 2 views

Therapy-related acute myelogenous leukemia and myelodysplastic syndrome (t-AML/ MDS) are being reported with increasing frequency as a complication of ABMT for Hodgkin's disease and non-Hodgkin's lymphoma. At present there is no method available to predict who is at risk or is destined to develop th

13: The Outcome of Allogeneic Stem Cell

13: The Outcome of Allogeneic Stem Cell Transplantation (alloSCT) for the Treatment of Therapy-Related Myelodysplastic Syndrome (tMDS) and Acute Myeloid Leukemia (tAML) Varies Considerably by Risk Factor: An Observational Study From the Center for International Blood and Marrow Transplant Research (CIBMTR)

✍ M.R. Litzow; W.S. Pérez; S. Tarima; A. Keating; J. Sierra; M.S. Tallman; D.J. We 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 54 KB